Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer
AbstractBackgroundStandard therapy for advanced endometrial cancer after failure of platinum-based chemotherapy remains unclear.MethodsIn this phase 3 trial, we randomly assigned, in a 1:1 ratio, patients...